# ARS Pharmaceuticals, Inc.: Form DEF 14A, filed Apr 29, 2025

- Company: [ARS Pharmaceuticals, Inc.](/companies/spry.md) (CIK 1671858)
- Form: DEF 14A
- Filed: 2025-04-29
- Accepted by EDGAR: Apr 29, 2025, 16:01 ET
- Period: 2025-06-25
- Accession: 0000950170-25-060075
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1671858/000095017025060075/spry-20250429.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1671858/000095017025060075/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1671858/000095017025060075/spry-20250429.htm

Filed Apr 29, 2025.
Source: SEC EDGAR, the filing index for accession 0000950170-25-060075. Last ingested by Listed: Oct 30, 2026, 16:39 ET. No prices; not investment advice.